Syndax Pharmaceuticals News, Syndax Pharmaceuticals Quote, SNDX Quote

Syndax Pharmaceuticals (NQ:SNDX) Delayed: 20.80 -0.17 (0.81%)

Prev. Close

$20.97

Open

$21.02

52 Wk High

$18.03

52 Wk Low

$8.97

Day High

$21.17

Day Low

$20.64

P/E

N/A

EPS

$0.00

Volume

158,870

Friends, Peers and Foes (?): INCY ZYME (more...)

Apr 10, 2024 04:05 PM Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum
Apr 8, 2024 07:22 AM Syndax Pharmaceuticals (SNDX) Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session
Apr 8, 2024 07:00 AM Syndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session
Apr 5, 2024 04:05 PM Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Apr 2, 2024 04:31 PM Form ARS Syndax Pharmaceuticals For: Dec 31
Apr 2, 2024 04:02 PM Form DEFA14A Syndax Pharmaceuticals
Apr 2, 2024 04:01 PM Form DEF 14A Syndax Pharmaceuticals For: Mar 27
Mar 28, 2024 07:00 AM Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia
Mar 28, 2024 06:01 AM Zymeworks (ZYME) Appoints Neil Gallagher to its Board
Mar 28, 2024 06:00 AM Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

Entities mentioned with SNDX